Recent

% | $
Quotes you view appear here for quick access.

Neuralstem, Inc. Message Board

  • joejoepepitone joejoepepitone Apr 28, 2014 10:26 AM Flag

    CUR and BCLI are #1, #2 ALS Stem Cell Picks

    BCLI now officially #2. Today announced Phase 2 FDA Approval for testing at MAYO, Mass General , and U.Mass. Both companies will be big winners. CUR may have a slight lead timewise, but BCLI has opportunity for greater capital appreciation as it becomes more widely known and appreciated.

 
CUR
1.48+0.13(+9.63%)Aug 27 4:00 PMEDT